OptiNose, Inc.
Pharmaceutical company · Yardley, Pennsylvania, United States
OptiNose, Inc. is a pharmaceutical company headquartered in Yardley, Pennsylvania, United States. Its earliest recorded incorporation is in 2010. It has reported private securities offerings to the US SEC, most recently $4.7 million sold in a notice filed in 2024.
OptiNose at a glance
What does OptiNose do?
Private fundraising reported to the SEC
9 Form D notices; the most recent reported $4.7 million sold (2024).
Frequently asked questions about OptiNose
Where is OptiNose headquartered?
OptiNose, Inc. is headquartered in Yardley, Pennsylvania, United States.
What does OptiNose do?
OptiNose, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was OptiNose founded?
The earliest incorporation on record for OptiNose, Inc. is in 2010, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences